
Advaxis
Clinical-stage biotechnology company developing immunotherapies for cancer and infectious diseases.
Market cap
$1.2m
Enterprise value
$5m
Share price
$0.03 ADXS
Authorizing premium user...
Clinical-stage biotechnology company developing immunotherapies for cancer and infectious diseases.